Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 14, 2018 16:05 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics Announces First Quarter 2018 Financial Results and Provides Corporate Update

RANCHO CORDOVA, Calif., May 14, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today...
May 09, 2018 08:30 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics to Announce Financial Results for the First Quarter Ended March 31, 2018 and Host Conference Call on May 14

RANCHO CORDOVA, Calif., May 09, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca” or the “Company”) (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous...
May 04, 2018 17:00 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics Inc. Presents New Data on its Proprietary X-Series™ Cellular Processing Systems

Two posters presented at the International Society for Cellular Therapy (ISCT)2018 Annual Meeting RANCHO CORDOVA, Calif., May 04, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca” or the...
April 25, 2018 08:30 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics Inc. to Exhibit at Several Upcoming Cell Therapy Conferences

RANCHO CORDOVA, Calif., April 25, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca” or the “Company”) (NASDAQ:KOOL) today announced that the Company will be exhibiting its full suite of...
April 24, 2018 08:30 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics Announces Evaluation Agreement With The University Of North Carolina Lineberger Advanced Cellular Therapeutics Facility for X-Series™ Products That Provide Automated, Closed System Cellular Processing

RANCHO CORDOVA, Calif., April 24, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies,...
April 17, 2018 08:30 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics Announces First Evaluation Agreement With a Leading U.S. Academic Research Institution for X-Series™ Products That Provide Automated, Closed System Cellular Processing

RANCHO CORDOVA, Calif., April 17, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies,...
April 03, 2018 08:30 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics Inc. Announces Release of X-Mini™ Cell Selection Kit for the CAR-T Research Market

RANCHO CORDOVA, Calif., April 03, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca”) (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based...
March 28, 2018 07:00 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics Inc. Announces Two Abstracts Accepted for Poster Presentation at the International Society for Cellular Therapy (ISCT) 2018 Annual Meeting

RANCHO CORDOVA, Calif., March 28, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca”) (NASDAQ:KOOL) today announced that two late-breaking abstracts involving the use of Cesca’s X-Series™...
March 26, 2018 09:00 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics Announces Registered Direct Offering

RANCHO CORDOVA, Calif., March 26, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (Nasdaq:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies,...
March 22, 2018 16:05 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics Announces Financial Results for the Transition Period July 1, 2017 to December 31, 2017, and Provides Corporate Update

RANCHO CORDOVA, Calif., March 22, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies,...